Avail Bio
San Francisco, United States · Founded 2018
- Headquarters
- San Francisco, California
- Founded
- 2018
- Business Model
- B2B
- Website
- avail.bio
- Last Round
- SeedOct 2018
- Rounds
- 1
About
Avail Bio is a venture-backed genomic biotechnology company advancing synthetic immunology for cancer treatment. The company couples mammalian synthetic biology with informatics to engineer immune cells with improved therapeutic properties. Avail Bio focuses on immunotherapy applications, particularly in oncology, developing companion diagnostics and next-generation cell therapy platforms. The company was part of the BIO Investor Forum and has been cited in peer-reviewed cancer immunotherapy research.
Summary
Avail Bio is a Biotech company based in San Francisco, United States, founded in 2018. Its most recent funding was a Seed round in Oct 2018. Investors include Fifty Years and First In.
Sign up to view the funding chart
Create a free account — you'll get 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Oct 2018
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...